Webinars

KMK-WEB-Site-version-MV-3_html_html_4a612293

KMK Regulatory Services Inc. offers as series of free GHS Webinars designed to inform participants of the many changes and differences within the various Revision (GHS version) that have been adopted in various countries. One of these, “Introduction to GHS” is targeted to Executive level management and mid management. Our goal is to assist EHS professionals to communicate and inform management of the impact to their business, regulated documents, labeling and personnel. A clearly defined, 3 step program is recommended to ensure full-compliance with GHS, worldwide.

Other webinars discuss the various unique characteristics in labeling, employee training and trade secrets. All these webinars are free of charge and followed by a Q & A period to satisfy concerns of all participants.

KMK-WEB-Site-version-MV-3_html_html_m44bc5adb

Introduction to GHS

In this Webinar, we introduce the challenges to all businesses with the various GHS Revisions has it is implemented in North America and worldwide. We provide clear explanation as to why regulated countries all over the world have adopted the standard “GHS”, and how chemical companies are adjusting to new Classifications, new Regulated documents and the new Hazards all employees need to be trained on.

KMK-WEB-Site-version-MV-3_html_html_m1c7c98aa

GHS Label Requirements

The worldwide GHS classifications require country' specific labeling! This specific classification may very well impacts the content of your labels? Are different hazards and pictograms needed on your labels for Canada compared to your labels for Japan, France or Brazil? Will you need, or not, to write the name of hazardous ingredients on your labels, based on your finished product' country of destinations? Do you need to add other regulatory information (Proposition 65) on your labels, for shipments to the United States?

Luc_seguin

Trade Secrets in the GHS era

This webinar identifies the specifics, in regards with trade secrets, that are still enforced, even after the adoption of GHS. What needs to be disclosed and to which governmental agencies? How do I communicate with Health Canada and at what cost? How does the trade secret registration work in Europe?